HER2 IHC score 3+/oestrogen receptor‐negative tumours were significantly associated with HER2‐related morphometric features compared to other HER2 classes including HER2 IHC 2+ with gene amplification, and they showed the least intra‐tumour morphological heterogeneity. This evidence concerns the gene ERBB2 and neoplasm.